UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Anesthesia for patients having deep brain stimulator implantation

Author
Lashmi Venkatraghavan, MD
Section Editor
Jeffrey J Pasternak, MD
Deputy Editor
Marianna Crowley, MD

INTRODUCTION

Deep brain stimulation (DBS) is used to treat Parkinson disease and other neurologic conditions, as well as certain psychiatric disorders such as obsessive-compulsive disorder [1-4]. The indications for DBS have now expanded to include other conditions, and the number of centers performing this procedure has also increased [1,4-10]. The DBS system provides advantages over traditional surgical ablative procedures such as thalamotomy and pallidotomy, because it is non-destructive, reversible, and adjustable [2].

This topic discusses perioperative anesthetic management and potential perioperative complications in patients undergoing DBS implantation. Also, the anesthetic implications of a pre-existing implanted DBS system are discussed, since these patients may undergo subsequent surgical procedures. (See "Surgical treatment of Parkinson disease", section on 'Deep brain stimulation' and "Deep brain stimulation for treatment of obsessive-compulsive disorder" and "Treatment of dystonia", section on 'Deep brain stimulation' and "Surgical treatment of essential tremor", section on 'Deep brain stimulation'.)

SURGICAL PROCEDURE

The deep brain stimulation (DBS) hardware has three main components:

Multi-contact intracranial quadripolar electrodes

A programmable single- or dual-channel internal pulse generator (IPG) with battery unit

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Fri Jan 08 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Miocinovic S, Somayajula S, Chitnis S, Vitek JL. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol 2013; 70:163.
  2. Venkatraghavan L, Luciano M, Manninen P. Review article: anesthetic management of patients undergoing deep brain stimulator insertion. Anesth Analg 2010; 110:1138.
  3. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337:403.
  4. Shah RS, Chang SY, Min HK, et al. Deep brain stimulation: technology at the cutting edge. J Clin Neurol 2010; 6:167.
  5. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010; 51:899.
  6. Mandat T, Koziara H, Tutaj M, et al. Thalamic deep brain stimulation for tremor among multiple sclerosis patients. Neurol Neurochir Pol 2010; 44:542.
  7. Laxton AW, Tang-Wai DF, McAndrews MP, et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 2010; 68:521.
  8. Lipsman N, Woodside DB, Giacobbe P, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet 2013; 381:1361.
  9. Johnson MD, Miocinovic S, McIntyre CC, Vitek JL. Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics 2008; 5:294.
  10. Marangell LB, Martinez M, Jurdi RA, Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand 2007; 116:174.
  11. Foltynie T, Zrinzo L, Martinez-Torres I, et al. MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J Neurol Neurosurg Psychiatry 2011; 82:358.
  12. Rezai AR, Kopell BH, Gross RE, et al. Deep brain stimulation for Parkinson's disease: surgical issues. Mov Disord 2006; 21 Suppl 14:S197.
  13. Khatib R, Ebrahim Z, Rezai A, et al. Perioperative events during deep brain stimulation: the experience at cleveland clinic. J Neurosurg Anesthesiol 2008; 20:36.
  14. Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005; 56:722.
  15. Gorgulho A, De Salles AA, Frighetto L, Behnke E. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg 2005; 102:888.
  16. Deiner S, Hagen J. Parkinson's disease and deep brain stimulator placement. Anesthesiol Clin 2009; 27:391.
  17. Poon CC, Irwin MG. Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices. Br J Anaesth 2009; 103:152.
  18. Nicholson G, Pereira AC, Hall GM. Parkinson's disease and anaesthesia. Br J Anaesth 2002; 89:904.
  19. Kaye AD, Lie H, Fox C, Baluch A. Psychiatric and behavioral disorders. In: Anesthesia and Uncommon Diseases, 6th ed, Fleisher LA. (Ed), WB Saunders, Philadelphia 2012. p.444.
  20. Sebeo J, Deiner SG, Alterman RL, Osborn IP. Anesthesia for pediatric deep brain stimulation. Anesthesiol Res Pract 2010; 2010.
  21. Osborn I, Sebeo J. "Scalp block" during craniotomy: a classic technique revisited. J Neurosurg Anesthesiol 2010; 22:187.
  22. Velly LJ, Rey MF, Bruder NJ, et al. Differential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia. Anesthesiology 2007; 107:202.
  23. Venkatraghavan L, Manninen P, Mak P, et al. Anesthesia for functional neurosurgery: review of complications. J Neurosurg Anesthesiol 2006; 18:64.
  24. Rozet I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol 2008; 21:537.
  25. Elias WJ, Durieux ME, Huss D, Frysinger RC. Dexmedetomidine and arousal affect subthalamic neurons. Mov Disord 2008; 23:1317.
  26. Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006; 103:1224.
  27. Tedder A, Manninen P, Venkatraghavan L. Profound hypertension with dexmedetomidine during insertion of deep brain stimulator. J Neuroanaesthesiol Crit Care 2015; 2:55.
  28. Fábregas N, Rapado J, Gambús PL, et al. Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery. Anesthesiology 2002; 97:1378.
  29. Maciver MB, Bronte-Stewart HM, Henderson JM, et al. Human subthalamic neuron spiking exhibits subtle responses to sedatives. Anesthesiology 2011; 115:254.
  30. Davies A. Midazolam-induced dyskinesia. Palliat Med 2000; 14:435.
  31. Huchison WD, Lozano AM. Microelectrode recordings in movement disorder surgery. In: Movement Disorder Surgery, Lozano AM. (Ed), Basel, Karger 2000.
  32. Lin SH, Chen TY, Lin SZ, et al. Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: a preliminary study. J Neurosurg 2008; 109:238.
  33. Air EL, Ostrem JL, Sanger TD, Starr PA. Deep brain stimulation in children: experience and technical pearls. J Neurosurg Pediatr 2011; 8:566.
  34. Raz A, Eimerl D, Zaidel A, et al. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients. Anesth Analg 2010; 111:1285.
  35. Maltête D, Navarro S, Welter ML, et al. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol 2004; 61:390.
  36. Chen SY, Tsai ST, Lin SH, et al. Subthalamic deep brain stimulation in Parkinson's disease under different anesthetic modalities: a comparative cohort study. Stereotact Funct Neurosurg 2011; 89:372.
  37. Suarez S, Ornaque I, Fábregas N, et al. Venous air embolism during Parkinson surgery in patients with spontaneous ventilation. Anesth Analg 1999; 88:793.
  38. Deogaonkar A, Avitsian R, Henderson JM, Schubert A. Venous air embolism during deep brain stimulation surgery in an awake supine patient. Stereotact Funct Neurosurg 2005; 83:32.
  39. Hooper AK, Okun MS, Foote KD, et al. Venous air embolism in deep brain stimulation. Stereotact Funct Neurosurg 2009; 87:25.
  40. Johnson RD, Qadri SR, Joint C, et al. Perioperative seizures following deep brain stimulation in patients with multiple sclerosis. Br J Neurosurg 2010; 24:289.
  41. Zrinzo L, Foltynie T, Limousin P, Hariz MI. Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg 2012; 116:84.
  42. Okun MS, Rodriguez RL, Foote KD, et al. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders. Parkinsonism Relat Disord 2008; 14:532.
  43. Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol 2008; 255 Suppl 4:2.
  44. Venkatraghavan L, Chinnapa V, Peng P, Brull R. Non-cardiac implantable electrical devices: brief review and implications for anesthesiologists. Can J Anaesth 2009; 56:320.
  45. Healey JS, Merchant R, Simpson C, et al. Society position statement : Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices. Can J Anaesth 2012; 59:394.
  46. Martin WA, Camenzind E, Burkhard PR. ECG artifact due to deep brain stimulation. Lancet 2003; 361:1431.
  47. Martinelli PT, Schulze KE, Nelson BR. Mohs micrographic surgery in a patient with a deep brain stimulator: a review of the literature on implantable electrical devices. Dermatol Surg 2004; 30:1021.
  48. Weaver J, Kim SJ, Lee MH, Torres A. Cutaneous electrosurgery in a patient with a deep brain stimulator. Dermatol Surg 1999; 25:415.
  49. Nutt JG, Anderson VC, Peacock JH, et al. DBS and diathermy interaction induces severe CNS damage. Neurology 2001; 56:1384.
  50. Henderson JM, Tkach J, Phillips M, et al. Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery 2005; 57:E1063; discussion E1063.
  51. Spiegel J, Fuss G, Backens M, et al. Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg 2003; 99:772.
  52. Larson PS, Richardson RM, Starr PA, Martin AJ. Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg 2008; 86:92.